Analyst Ratings for Y-mAbs Therapeutics (YMAB)
YMAB Rating Summary
YMAB Price Target Summary
- Highest: $8.60 (Wedbush)
- Lowest: $8.60 (Wedbush)
- Average: $8.60
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$8.60 (-0.1%)
* Over Last 12-Mos
Rating Score: 2.4 / 10
Percentile Rank: 18%
Rating Score: 2.4 / 10
Percentile Rank: 18%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/6/2025 | H.C. Wainwright | Robert Burns | Downgrade | Neutral (Buy) |
N/A (N/A) |
8.52 (8.61) |
1.06% | Details |
| 8/6/2025 | Canaccord | William Maughan | Downgrade | Hold (Buy) |
N/A (N/A) |
4.19 (8.61) |
105.49% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
